Jim Cramer on Hinge Health: “This Is Actually a Really Good Time to Buy It”

Jim Cramer reviewed Hinge Health, Inc. (NYSE:HNGE) while breaking down 16 stocks for a market facing higher energy costs and economic uncertainty. A caller asked what Cramer thinks of the stock, and he said:

When we did a profile of it, I said you should buy it between $30 and $40. It looked good. I reiterate that this is a very good healthcare company… This is actually a really good time to buy it. It’s a very recession-proof stock, too, so I think you got a good one.

Photo by Joshua Mayo on Unsplash

Hinge Health, Inc. (NYSE:HNGE) develops digital health software focused on musculoskeletal care, covering injury recovery, chronic pain management, and post-surgical rehabilitation. During the February 26 episode, a caller asked about the stock, and Cramer showed a bullish sentiment toward it. The Mad Money host commented:

Oh, we like Hinge Health. We like Hinge Health. It’s just kind of when like Medline the other day, it’s just going to quietly go higher. It’s up three points today. That’s a very big move. But when I see a stock like Hinge Health, I just say, okay, look, it’s got a model for patient education to help the patients. They seem like level-headed people, and I just say buy that one and put it away. I think that was going to do well for a long time.

While we acknowledge the risk and potential of HNGE as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than HNGE and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years 

Disclosure: None. Follow Insider Monkey on Google News.